Drug patents …
… from Kazakhstan to Kalamazoo
Anticipate generic drug launch
Manage your formulary budget
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Proactively manage your pharmacy inventory
Find generic entry opportunities
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
|Abstract:||A hydromorphone composition, a hydromorphone dosage form and a method for administering hydromorphone are disclosed, indicated for the management of pain.|
|Inventor(s):||Merrill; Sonya (San Jose, CA), Ayer; Atul Devdatt (Palo Alto, CA), Chadha; Navjot (Sunnyvale, CA), Kuczynski; Anthony L. (Mt. View, CA)|
|Assignee:||Alza Corporation (Palo Alto, CA)|
Patent Claim Types:|
see list of patent claims
|Composition; Dosage form; Use; Delivery;|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|Austria||227575||<disabled in preview>|
|Austria||230992||<disabled in preview>|
|Australia||2908395||<disabled in preview>|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.